NOVO NORDISK INC. for NOVO NORDISK INC.
What was lobbied
8 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Issues related to patent litigation and patent assertion entities (PAEs) aka patent trolls
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRICIA BROOKS | — |
| MICHAEL MAWBY | — |
| CHRISTOPHER MCGOWEN | — |
| SARAH ELIZABETH NORDSTROM | — |
| SHAYLAH NUNN | — |
| CHRISTOPHER PORTER | — |
| LAUREN ELIZABETH SEMENIUK | — |
| AMY CATHERINE THIENEL | — |
Health Issues HCR
National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), Prevention and Public Health Fund, AHRQ and USPSTF diabetes screening standards;diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S. 539 National Diabetes Clinical Care Commission Act of 2013; human growth / rare disorders awareness; H.R. 8 American Taxpayer Relief Act (Special Diabetes Program reauthorization); gestational diabetes; diabetes disparities; H.R. 351 and S. 351 Protecting Seniors' Access to Medicare Act of 2013 (IPAB repeal)
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRICIA BROOKS | — |
| MICHAEL MAWBY | — |
| CHRISTOPHER MCGOWEN | — |
| SARAH ELIZABETH NORDSTROM | — |
| SHAYLAH NUNN | — |
| CHRISTOPHER PORTER | — |
| LAUREN ELIZABETH SEMENIUK | — |
| AMY CATHERINE THIENEL | — |
Medicare/Medicaid MMM
H.R. 962 and S. 452 Medicare Diabetes Prevention Act of 2013; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011, H.R. 8 American Taxpayer Relief Actof 2012, and H.R. 1588 and S. 740 Medicare Drug Savings Act of 2013; H.R. 1257 Preventing Diabetes in Medicare Act of 2013 and prediabetes generally; H.R. 1274 and S. 945 Access to Quality Diabetes Education Act of 2013 (Diabetes Self-Management Training in Medicare);Medicare diabetes screening generally; S. 1184 and H.R. 2415 Treat and Reduce Obesity Act of 2013; Physician Quality and Reporting System (PQRS)
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRICIA BROOKS | — |
| MICHAEL MAWBY | — |
| CHRISTOPHER MCGOWEN | — |
| SARAH ELIZABETH NORDSTROM | — |
| SHAYLAH NUNN | — |
| CHRISTOPHER PORTER | — |
| LAUREN ELIZABETH SEMENIUK | — |
| AMY CATHERINE THIENEL | — |
Budget/Appropriations BUD
Issues related to Medicare Part D, FDA and patents in S. Con. Res. 8 FY14 Senate Budget Resolution; H. Con. Res. 25 House Budget Resolution; H.R. 2663 The Preventative Health Savings Act of 2013 (Modernizing CBO scoring estimates with respect to preventive health legislation); National Diabetes Prevention Program in H.R. 933 -- FY13 Consolidated and Further Continuing Appropriations Act and S. 1284 FY14 Depts. of Labor, Health and Human Services, and Education Appropriations Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRICIA BROOKS | — |
| MICHAEL MAWBY | — |
| CHRISTOPHER MCGOWEN | — |
| SARAH ELIZABETH NORDSTROM | — |
| SHAYLAH NUNN | — |
| CHRISTOPHER PORTER | — |
| LAUREN ELIZABETH SEMENIUK | — |
| AMY CATHERINE THIENEL | — |
Pharmacy PHA
H.R.1919 Safeguarding America's Pharmaceuticals Act of 2013 and S.959 Pharmaceutical Compounding Quality and Accountability Act (for track and trace supply chain provisions); issues regarding biosimilars; 340B
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRICIA BROOKS | — |
| MICHAEL MAWBY | — |
| CHRISTOPHER MCGOWEN | — |
| SARAH ELIZABETH NORDSTROM | — |
| SHAYLAH NUNN | — |
| CHRISTOPHER PORTER | — |
| LAUREN ELIZABETH SEMENIUK | — |
| AMY CATHERINE THIENEL | — |
Trade (domestic/foreign) TRD
EU/US Transatlantic Trade and Investment Partnership (TTIP) (intellectual property); Trans-Pacific Partnership (TPP) (intellectual property)
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRICIA BROOKS | — |
| MICHAEL MAWBY | — |
| CHRISTOPHER MCGOWEN | — |
| SARAH ELIZABETH NORDSTROM | — |
| SHAYLAH NUNN | — |
| CHRISTOPHER PORTER | — |
| LAUREN ELIZABETH SEMENIUK | — |
| AMY CATHERINE THIENEL | — |
Taxation/Internal Revenue Code TAX
H.R. 8 American Taxpayer Relief Act (R&D tax credit) of 2012 (R&D credit); H.R. 2052 and S. 1023 Global Investment in American Jobs Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRICIA BROOKS | — |
| MICHAEL MAWBY | — |
| CHRISTOPHER MCGOWEN | — |
| SARAH ELIZABETH NORDSTROM | — |
| SHAYLAH NUNN | — |
| CHRISTOPHER PORTER | — |
| LAUREN ELIZABETH SEMENIUK | — |
| AMY CATHERINE THIENEL | — |
Veterans VET
Issues related to insulin pen safety and access in the VA
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRICIA BROOKS | — |
| MICHAEL MAWBY | — |
| CHRISTOPHER MCGOWEN | — |
| SARAH ELIZABETH NORDSTROM | — |
| SHAYLAH NUNN | — |
| CHRISTOPHER PORTER | — |
| LAUREN ELIZABETH SEMENIUK | — |
| AMY CATHERINE THIENEL | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| NOVO NORDISK FONDEN (FOUNDATION) | Denmark | Denmark | 25.5% | — |
| NOVO NORDISK A/S | Denmark | Denmark | 100.0% | — |
| NOVO A/S | Denmark | Denmark | 25.5% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.